TLC Laser Eye Centres

TLC-T

0.00
0.00 (0.00%)
This company is not ACTIVE.

Analysis and Opinions about TLC-T

Signal
Opinion
Expert
DON'T BUY
DON'T BUY
December 24, 2007
This is on his Stock Watch list. Balance sheet is pretty dirty with a lot of debt. Company is trying to make major changes, but at this point the risk is far too great for him. Likes the field, which is a growing one.
Show full opinionHide full opinion
This is on his Stock Watch list. Balance sheet is pretty dirty with a lot of debt. Company is trying to make major changes, but at this point the risk is far too great for him. Likes the field, which is a growing one.
WATCH
WATCH
September 15, 2006
May have reached its bottom in August. Check the volume from that point. In order to have a bottom, you want 3 X the average volume, a rally and then a correction. If it does not make a new low, that is your signal to buy.
Show full opinionHide full opinion
TLC Laser Eye Centres (TLC-T)
September 15, 2006
May have reached its bottom in August. Check the volume from that point. In order to have a bottom, you want 3 X the average volume, a rally and then a correction. If it does not make a new low, that is your signal to buy.
DON'T BUY
DON'T BUY
September 14, 2006
Doesn't see anything in the metrics that makes it appealing. Too risky. Has a lot of competition.
Show full opinionHide full opinion
TLC Laser Eye Centres (TLC-T)
September 14, 2006
Doesn't see anything in the metrics that makes it appealing. Too risky. Has a lot of competition.
WEAK BUY
WEAK BUY
August 31, 2006
His problem with the stock is that there is only one estimate, so the information given may not be that good. The model price shows as $9.90, a 65% positive differential. Be cautious
Show full opinionHide full opinion
His problem with the stock is that there is only one estimate, so the information given may not be that good. The model price shows as $9.90, a 65% positive differential. Be cautious
DON'T BUY
DON'T BUY
August 28, 2006
Doing very poorly against their US competitor LCA Vision (LCAV-Q). Also had problems with their subsidiary Occulogix when their clinical trial failed. Starting to get beaten up enough to maybe start paying attention to it.
Show full opinionHide full opinion
Doing very poorly against their US competitor LCA Vision (LCAV-Q). Also had problems with their subsidiary Occulogix when their clinical trial failed. Starting to get beaten up enough to maybe start paying attention to it.
DON'T BUY
DON'T BUY
August 18, 2006
The real problem has been the irregularity of their earnings. Don't seem to have quarterly momentum in their financials. Increasing competition.
Show full opinionHide full opinion
The real problem has been the irregularity of their earnings. Don't seem to have quarterly momentum in their financials. Increasing competition.
SELL
SELL
October 17, 2005
Below its 200 day moving average and just recently hit a new low.
Show full opinionHide full opinion
Below its 200 day moving average and just recently hit a new low.
WEAK BUY
WEAK BUY
June 9, 2005
Expensive. Model price is $13.08, so there is a discount and value. Trades at a high multiple to book. If they ever stumble it would sink like a stone.
Show full opinionHide full opinion
Expensive. Model price is $13.08, so there is a discount and value. Trades at a high multiple to book. If they ever stumble it would sink like a stone.
DON'T BUY
DON'T BUY
May 10, 2005
Also owns a US company LCA Vision (LCAV-Q) and have been selling his TLC shares to buy LCA. Feels LCA is a better run company on the laser vision procedures.
Show full opinionHide full opinion
Also owns a US company LCA Vision (LCAV-Q) and have been selling his TLC shares to buy LCA. Feels LCA is a better run company on the laser vision procedures.
VAGUE
VAGUE
March 15, 2005
The chart looks like it's trying to form a base. Don't let it make a 52 week low on you. If there is an oil shock and rates go up, it could hurt.
Show full opinionHide full opinion
The chart looks like it's trying to form a base. Don't let it make a 52 week low on you. If there is an oil shock and rates go up, it could hurt.
DON'T BUY
DON'T BUY
December 13, 2004
Has been a pretty bumpy ride and still well down from where they were 4/5 years ago. The merger with OccuLogix seems to be a sensible deal. On a 4/5 year basis it is probably going to end up as one of the consolidators. Not sure they will make enough money to make it worthwhile.
Show full opinionHide full opinion
Has been a pretty bumpy ride and still well down from where they were 4/5 years ago. The merger with OccuLogix seems to be a sensible deal. On a 4/5 year basis it is probably going to end up as one of the consolidators. Not sure they will make enough money to make it worthwhile.
BUY
BUY
December 1, 2004
Got up to $17 this year and had a correction. Has stayed in the $10/12 area for several months. It is now starting a new upleg. Just went above its 200 day moving average.
Show full opinionHide full opinion
Got up to $17 this year and had a correction. Has stayed in the $10/12 area for several months. It is now starting a new upleg. Just went above its 200 day moving average.
BUY WEAKNESS
BUY WEAKNESS
November 30, 2004
Model price is $31.25, so fully priced. Seems to go through a boom/bust cycle twice a year.
Show full opinionHide full opinion
Model price is $31.25, so fully priced. Seems to go through a boom/bust cycle twice a year.
PAST TOP PICK
PAST TOP PICK
August 24, 2004
(A Top Pick Mar 17/04. Down 26%.) Sold out near its top in May. Coming back to a support level at around $10 and could be a chance to buy it back.
Show full opinionHide full opinion
(A Top Pick Mar 17/04. Down 26%.) Sold out near its top in May. Coming back to a support level at around $10 and could be a chance to buy it back.
BUY
BUY
May 12, 2004
Has dropped because there will be a delay in spinning off its Rheopheresis blood filtration process. Interesting speculation. Fundamentals have been improving so it looks good at this price.
Show full opinionHide full opinion
Has dropped because there will be a delay in spinning off its Rheopheresis blood filtration process. Interesting speculation. Fundamentals have been improving so it looks good at this price.
Showing 1 to 15 of 47 entries

TLC Laser Eye Centres(TLC-T) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for TLC Laser Eye Centres is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

TLC Laser Eye Centres(TLC-T) Frequently Asked Questions

What is TLC Laser Eye Centres stock symbol?

TLC Laser Eye Centres is a OTC stock, trading under the symbol TLC-T on the (). It is usually referred to as or TLC-T

Is TLC Laser Eye Centres a buy or a sell?

In the last year, there was no coverage of TLC Laser Eye Centres published on Stockchase.

Is TLC Laser Eye Centres a good investment or a top pick?

TLC Laser Eye Centres was recommended as a Top Pick by Benj Gallander on 2007-12-24. Read the latest stock experts ratings for TLC Laser Eye Centres.

Why is TLC Laser Eye Centres stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is TLC Laser Eye Centres worth watching?

In the last year 0 stock analyst on Stockchase covered TLC Laser Eye Centres. The stock is worth watching.

What is TLC Laser Eye Centres stock price?

On , TLC Laser Eye Centres (TLC-T) stock closed at a price of $.